DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: How KRAS Mutations Impair Intrinsic GTP Hydrolysis: Experimental and Computational Investigations

Journal Article · · Journal of Chemical Information and Modeling
 [1];  [2]; ORCiD logo [3];  [3];  [3];  [3];  [3];  [4]; ORCiD logo [2];  [5]
  1. Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States); Westlake Pharmaceuticals, Hangzhou (China)
  2. Frederick National Laboratory for Cancer Research, Frederick, MD (United States)
  3. Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
  4. Frederick National Laboratory for Cancer Research, Frederick, MD (United States); Univ. of California, San Francisco, CA (United States)
  5. Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States); BridgeBio Inc., Palo Alto, CA (United States)

Oncogenic KRAS mutations impair GTP hydrolysis and increase the active GTP-bound KRAS population, which leads to growth-factor-independent cell proliferation and survival of cancer cells. Despite notable successes of small-molecule inhibitors in the treatment of KRASG12C cancer, many of these small-molecule inhibitors preferentially bind to inactive (GDP-bound) mutant KRAS, whose availability is limited by the slow rate of intrinsic GTP hydrolysis. A better understanding of how KRAS mutations impair intrinsic hydrolysis is important for designing more effective small-molecule therapeutics. In this work, experimental and computational approaches were utilized to investigate how the most important oncogenic mutations affect the intrinsic hydrolysis of GTP. Here, we found that Q61H, G12V, and G12R mutations impair intrinsic hydrolysis by around 7-fold, 9-fold, and more than 20-fold, respectively, whereas G12A, G12C, G12D, and G13D have less effect. Based on mechanistic investigations, we propose that KRAS mutations impair intrinsic hydrolysis by disrupting the interactions needed to align the nucleophilic water molecule with GTP for nucleophilic attack. These results can assist small-molecule inhibitor design and also benefit the development of other therapeutic strategies, such as rescuing hydrolysis.

Research Organization:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE Laboratory Directed Research and Development (LDRD) Program; USDOE National Nuclear Security Administration (NNSA)
Grant/Contract Number:
AC52-07NA27344
OSTI ID:
3013995
Report Number(s):
LLNL--JRNL-849961
Journal Information:
Journal of Chemical Information and Modeling, Journal Name: Journal of Chemical Information and Modeling Journal Issue: 23 Vol. 65; ISSN 1549-9596; ISSN 1549-960X
Publisher:
American Chemical SocietyCopyright Statement
Country of Publication:
United States
Language:
English

References (75)

Development of polyphosphate parameters for use with the AMBER force field journal July 2003
THE weighted histogram analysis method for free-energy calculations on biomolecules. I. The method journal October 1992
Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations journal November 2006
Optimizing Expression and Solubility of Proteins in E. coli Using Modified Media and Induction Parameters book May 2017
Gateway Cloning for Protein Expression book January 2009
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes journal March 1977
Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch molecules journal August 1990
Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase journal November 1991
Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor journal May 1993
Electrostatic interaction of a solute with a continuum. A direct utilizaion of AB initio molecular potentials for the prevision of solvent effects journal February 1981
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis journal February 2022
Quantum chemical modeling of the GTP hydrolysis by the RAS–GAP protein complex journal July 2004
GEFs and GAPs: Critical Elements in the Control of Small G Proteins journal June 2007
Revealing the mechanism of action of a first-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31P NMR journal February 2024
Protein production by auto-induction in high-density shaking cultures journal May 2005
Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring journal February 2020
Ras Conformational Ensembles, Allostery, and Signaling journal January 2016
Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor journal December 2021
Hydrolysis of Guanosine Triphosphate (GTP) by the Ras·GAP Protein Complex: Reaction Mechanism and Kinetic Scheme journal September 2015
Specific Substates of Ras To Interact with GAPs and Effectors: Revealed by Theoretical Simulations and FTIR Experiments journal February 2018
Structure-Based Design and Evaluation of Reversible KRAS G13D Inhibitors journal December 2023
Recent Advances in Understanding Biological GTP Hydrolysis through Molecular Simulation journal February 2020
How Does GAP Catalyze the GTPase Reaction of Ras?:  A Computer Simulation Study journal July 2000
Ras Catalyzes GTP Hydrolysis by Shifting Negative Charges from γ - to β -Phosphate As Revealed by Time-Resolved FTIR Difference Spectroscopy journal March 2001
Role of Glutamine-61 in the Hydrolysis of GTP by p21H-ras: An Experimental and Theoretical Study journal March 1994
Conformational States of Ras Complexed with the GTP Analogue GppNHp or GppCH 2 p:  Implications for the Interaction with Effector Proteins journal February 2005
Transition State Structures and the Roles of Catalytic Residues in GAP-Facilitated GTPase of Ras As Elucidated by 18 O Kinetic Isotope Effects journal June 2009
DFTB3: Extension of the Self-Consistent-Charge Density-Functional Tight-Binding Method (SCC-DFTB) journal March 2011
Ab Initio Calculation of Vibrational Absorption and Circular Dichroism Spectra Using Density Functional Force Fields journal November 1994
Enzymatic GTP Hydrolysis:  Insights from an ab Initio Molecular Dynamics Study journal March 2002
Hydrogen Bonding between Amino Acid Backbone and Side Chain Analogues:  A High-Level ab Initio Study journal December 1997
Simultaneous Covalent Modification of K-Ras(G12D) and K-Ras(G12C) with Tunable Oxirane Electrophiles journal August 2023
GTP Hydrolysis Without an Active Site Base: A Unifying Mechanism for Ras and Related GTPases journal June 2019
Determination of Alkali and Halide Monovalent Ion Parameters for Use in Explicitly Solvated Biomolecular Simulations journal July 2008
Mechanism of activation of a human oncogene journal November 1982
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene journal November 1982
Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change journal December 1982
Biological properties of human c-Ha-ras1 genes mutated at codon 12 journal November 1984
RanGAP mediates GTP hydrolysis without an arginine finger journal February 2002
The KRAS crowd targets its next cancer mutations journal January 2023
The Rap–RapGAP complex: GTP hydrolysis without catalytic glutamine and arginine residues journal February 2008
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions journal November 2013
Substrate-assisted catalysis as a mechanism for GTP hydrolysis of p21ras and other GTP-binding proteins journal January 1995
KRAS mutation: from undruggable to druggable in cancer journal November 2021
RAS-targeted therapies: is the undruggable drugged? journal June 2020
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity journal October 2019
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth journal May 2023
Pharmacological restoration of GTP hydrolysis by mutant RAS journal October 2024
Comparison of simple potential functions for simulating liquid water journal July 1983
A complete basis set model chemistry. II. Open‐shell systems and the total energies of the first‐row atoms journal May 1991
Particle mesh Ewald: An N ⋅log( N ) method for Ewald sums in large systems journal June 1993
A smooth particle mesh Ewald method journal November 1995
Kinetic isotope effects in Ras-catalyzed GTP hydrolysis: Evidence for a loose transition state journal June 2004
A phosphoryl transfer intermediate in the GTPase reaction of Ras in complex with its GTPase-activating protein journal September 2006
Dynamic properties of the Ras switch I region and its importance for binding to effectors journal April 2001
Allosteric modulation of Ras positions Q61 for a direct role in catalysis journal March 2010
Quantitative exploration of the molecular origin of the activation of GTPase journal November 2013
Purification of ras GTPase activating protein from bovine brain. journal July 1988
Ras-catalyzed hydrolysis of GTP: a new perspective from model studies. journal August 1996
Conformational States of Human Rat Sarcoma (Ras) Protein Complexed with Its Natural Ligand GTP and Their Role for Effector Interaction and GTP Hydrolysis journal October 2010
The Mechanism for Activation of GTP Hydrolysis on the Ribosome journal November 2010
The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras Mutants journal July 1997
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS journal August 2023
The Frequency of Ras Mutations in Cancer journal March 2020
Abstract 1142: Discovery of FMC-376 a novel orally bioavailable inhibitor of activated KRASG12C journal April 2023
Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers journal April 2023
Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations journal June 2015
Atypical KRAS G12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer journal October 2019
Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants journal January 2022
Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C journal December 2024
Targeting KRAS mutant cancers: from druggable therapy to drug resistance journal August 2022
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors journal January 2022
More to the RAS Story: KRASG12C Inhibition, Resistance Mechanisms, and Moving Beyond KRASG12C journal July 2022
Small molecular inhibitors for KRAS-mutant cancers journal August 2023
Ras history: The saga continues journal July 2010

Similar Records

Revealing the mechanism of action of a first-in-class covalent inhibitor of $\mathrm{KRASG12C}$ $\mathrm{(ON)}$ and other functional properties of oncogenic $\text{KRAS}$ by 31P $\mathrm{NMR}$
Journal Article · Tue Jan 16 00:00:00 UTC 2024 · Journal of Biological Chemistry · OSTI ID:2345116

KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis
Journal Article · Mon Oct 14 00:00:00 UTC 2019 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:1570474

Exploring switch II pocket conformation of KRAS(G12D) with mutant-selective monobody inhibitors
Journal Article · Mon Jul 03 00:00:00 UTC 2023 · Proceedings of the National Academy of Sciences of the United States of America · OSTI ID:2423430